SB-649868 clinical trials
Also written SB-649868.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses SB-649868 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- SB-649868
- 7
Studies by the year they started
7 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 4 |
| 2009 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SB-649868 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Disturbed Sleep Model Study.CompletedPhase 1GlaxoSmithKlineNCT00440323Written as SB-649868
- 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.CompletedPhase 1GlaxoSmithKlineNCT00495729Written as SB-649868
- Bioequivalence and Food Effect Study in Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT00495274Written as Formulation A
- A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.CompletedPhase 1GlaxoSmithKlineNCT01299597Written as SB649868
- Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteersCompletedPhase 1GlaxoSmithKlineNCT01030939Written as SB-649868
- A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female PopulationWithdrawnPhase 1GlaxoSmithKlineNCT00534872Written as SB-649868
- To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary InsomniaCompletedPhase 2GlaxoSmithKlineNCT00426816Written as SB-649868
Codes
What other systems call SB-649868 · ClinicalTrials.gg INT005819
- Wikidata Q7388914SB-649868One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q7388914 | SB-649868 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.